IMMUNOGEN INC Uncategorized Contracts & Agreements
31 Contracts & Agreements
- Offer Letter dated as of September 18, 2023 between the Registrant and Lauren White (Filed With SEC on November 2, 2023)
- First Amendment to Offer Letter dated as of December 29, 2022 between the Registrant and Michael J. Vasconcelles (Filed With SEC on March 1, 2023)
- Offer Letter dated as of December 29, 2022 between the Registrant and Michael J. Vasconcelles (Filed With SEC on March 1, 2023)
- Description of Securities (Filed With SEC on March 1, 2023)
- First Amendment to Agreements dated as of December 9, 2013 by and between the Registrant and Eli Lilly and Company (Filed With SEC on February 28, 2022)
- Description of Securities (Filed With SEC on March 1, 2021)
- Open Market Sale AgreementSM, dated December 18, 2020, by and between ImmunoGen, Inc. and Jefferies LLC (Filed With SEC on December 18, 2020)
- Open Market Sale AgreementSM, dated September 25, 2020, by and between ImmunoGen, Inc. and Jefferies LLC (Filed With SEC on September 25, 2020)
- Description of Securities (Filed With SEC on March 11, 2020)
- Multi-Target Agreement, dated as of December 19, 2011, by and between the Company and Eli Lilly (Filed With SEC on May 9, 2018)
- Options Granted (Filed With SEC on December 13, 2016)
- Options Granted (Filed With SEC on December 13, 2016)
- Options Granted (Filed With SEC on December 13, 2016)
- Options Exercised (Filed With SEC on April 26, 2016)
- Options Exercised (Filed With SEC on April 26, 2016)
- 830 Winter Street Waltham, Massachusetts 02451 (the Building) THIRD AMENDMENT (Filed With SEC on February 4, 2016)
- CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on February 5, 2015)
- [ImmunoGen Letterhead] (Filed With SEC on October 30, 2014)
- CONFIDENTIAL TREATMENT REQUESTED FIRST AMENDMENT TO AGREEMENTS (Filed With SEC on February 5, 2014)
- FIRST AMENDMENT TO MULTI-TARGET AGREEMENT (Filed With SEC on May 6, 2013)
- Options Exercised (Filed With SEC on August 29, 2012)
- Options Exercised (Filed With SEC on August 29, 2012)
- Options Exercised (Filed With SEC on August 29, 2012)
- MULTI-TARGET AGREEMENT (Filed With SEC on May 10, 2012)
- MULTI-TARGET AGREEMENT (Filed With SEC on May 10, 2012)
- IMMUNOGEN, INC. 2006 EMPLOYEE, DIRECTOR AND CONSULTANT EQUITYINCENTIVE PLAN (as amended and restated through November 12, 2008) (Filed With SEC on November 14, 2008)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on June 23, 2008)
- PROPRIETARYINFORMATION, INVENTIONS, AND COMPETITION AGREEMENT (Filed With SEC on February 7, 2008)
- SEVERANCEAGREEMENT (Filed With SEC on February 7, 2008)
- SCALE UP AGREEMENT (Filed With SEC on August 30, 2007)
- ImmunoGen, Inc. (Filed With SEC on June 16, 2005)
